Integra Lifesciences's market cap is currently $1.15B. The company's EPS TTM is $0.45; its P/E ratio is ―; Integra Lifesciences is scheduled to report earnings on July 31, 2025, and the estimated EPS forecast is $0.43. See an overview of income statement, balance sheet, and cash flow financials.
